Endometriosis: New genetic approaches and therapy

被引:45
作者
Barlow, DH [1 ]
Kennedy, S [1 ]
机构
[1] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Obstet & Gynaecol, Womens Ctr, Oxford OX3 9DU, England
来源
ANNUAL REVIEW OF MEDICINE | 2005年 / 56卷
关键词
pelvic pain; infertility; genetics; linkage analysis;
D O I
10.1146/annurev.med.55.091902.103805
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Endometriosis is a relatively common condition in women of reproductive age and is associated with considerable morbidity. Despite an extensive literature describing its multiple clinical manifestations, their management, and many aspects of the biology of endometriotic lesions, the pathophysiological mechanisms involved remain poorly understood. A genetic component in endometriosis is now recognized, and several groups have taken up the challenge of using genetic techniques to identify the aberrant molecular and cellular mechanisms in endometriosis with the intention of providing much-needed insights that might, in turn, lead to new therapies. The techniques that have been applied include expression profiling, tumor genetic studies, functional candidate gene studies, and linkage studies that can adopt a hypothesis-free approach. This review describes the current status of these studies and explores the prospects for new therapies.
引用
收藏
页码:345 / 356
页数:12
相关论文
共 55 条
[1]   TREATMENT OF RECURRENT CHOCOLATE CYSTS BY TRANSVAGINAL ASPIRATION AND TETRACYCLINE SCLEROTHERAPY [J].
ABOULGHAR, MA ;
MANSOUR, RT ;
SEROUR, GI ;
SATTAR, M ;
RAMZY, AM ;
AMIN, YM .
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 1993, 10 (08) :531-533
[2]  
*AM FERT SOC, 1985, FERTIL STERIL, V43, P351
[3]  
Arimoto T, 2003, INT J ONCOL, V22, P551
[4]   Glutathione S-transferase M1 gene polymorphism and susceptibility to endometriosis in a French population [J].
Baranova, H ;
Bothorishvilli, R ;
Canis, M ;
Albuisson, E ;
Perriot, S ;
Glowaczower, E ;
Bruhat, MA ;
Baranov, V ;
Malet, P .
MOLECULAR HUMAN REPRODUCTION, 1997, 3 (09) :775-780
[5]   Somatic DNA alterations in endometriosis: high frequency of chromosome 17 and p53 loss in late-stage endometriosis [J].
Bischoff, FZ ;
Heard, M ;
Simpson, JL .
JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2002, 55 (1-2) :49-64
[6]   Molecular basis for treating endometriosis with aromatase inhibitors [J].
Bulun, SE ;
Zeitoun, KM ;
Takayama, K ;
Sasano, H .
HUMAN REPRODUCTION UPDATE, 2000, 6 (05) :413-418
[7]   Estrogen production in endometriosis and use of aromatase inhibitors to treat endometriosis [J].
Bulun, SE ;
Zeitoun, K ;
Takayama, K ;
Noble, L ;
Michael, D ;
Simpson, E ;
Johns, A ;
Putman, M ;
Sasano, H .
ENDOCRINE-RELATED CANCER, 1999, 6 (02) :293-301
[8]  
Coxhead Dawn, 1993, Journal of Obstetrics and Gynaecology (Abingdon), V13, P42, DOI 10.3109/01443619309151773
[9]   Endometriosis associated with the N314D mutation of galactose-1-phosphate uridyl transferase (GALT) [J].
Cramer, Daniel W. ;
Hornstein, M. D. ;
Ng, W. G. ;
Barbieri, R. L. .
MOLECULAR HUMAN REPRODUCTION, 1996, 2 (03) :149-152
[10]   Epidemiology of endometriosis [J].
Eskenazi, B ;
Warner, ML .
OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA, 1997, 24 (02) :235-+